About CureDM

CureDM is a biopharmaceutical company established to develop new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology Research
location icon
Phone number
610-645-6796
location icon
Headquarter
Wilmington, Delaware
description icon
Founded
2004

CureDM Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about CureDM

Who are the decision makers in CureDM?

The decision makers in CureDM are Donna Morrow, etc. Click to Find CureDM decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more